EUVIMEDEUVIMED entdecken
Crossref

The Effects of Galangin Mitigating Doxorubicin‐Induced Hepatorenal Injury

Fazile Nur Ekinci Akdemir iD, Mustafa Can Güler iD, Ersen Eraslan, Ayhan Tanyeli iD, Serkan Yildirim, Fatih Mehmet Kandemir iD, Sefa Küçükler iD

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.70669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Fazile Nur Ekinci Akdemir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Erzurum Medicine Faculty, Health Sciences University, Erzurum, Turkey. Hauptthemen laut MEDLINE: Doxorubicin, Flavonoids, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigates the protective effects of galangin (GAL) against doxorubicin (Dox)‐induced hepatorenal toxicity in a rat model, focusing on oxidative stress, inflammation, and key markers, including interleukin‐6 (IL‐6), 8‐hydroxydeoxyguanosine (8‐OHdG), and aquaporin‐1 (AQP‐1). Male Sprague‐Dawley rats were divided into four groups: Control, Dox, Dox+GAL 50 mg/kg, and Dox+GAL 100 mg/kg. GAL significantly attenuated Dox‐induced damage by reducing IL‐6 and 8‐OHdG levels, restoring AQP‐1 expression, and improving histopathological profiles. Biochemical analysis demonstrated GAL's antioxidant activity, evidenced by elevated levels of glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT), alongside decreased levels of malondialdehyde (MDA). These findings suggest GAL as a potential therapeutic agent for mitigating Dox‐induced organ toxicity, with broader implications for conditions involving oxidative stress and inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinFlavonoidsChemical and Drug Induced Liver InjuryAnimalsMaleRats, Sprague-DawleyRatsOxidative StressAntioxidantsInterleukin-6

Stichwörter der Autor:innen

doxorubicingalanginhepatorenal injuryinflammationoxidative stress

Substanzen

DoxorubicinFlavonoidsgalanginAntioxidantsInterleukin-6

Autor:innen und Institutionen

  • Department of Physiology, Erzurum Medicine Faculty, Health Sciences University, Erzurum, Turkey.
  • Department of Physiology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
  • Department of Physiology, Faculty of Medicine, Bandırma OnYedi Eylül University, Balıkesir, Turkey.
  • Department of Pathology, Faculty of Veterinary, Atatürk University, Erzurum, Turkey.
  • Department of Pathology, Faculty of Veterinary Medicine, Kyrgyz-Turkish Manas University, Bishkek, Kyrgyzstan.
  • Department of Biochemistry, Faculty of Medicine, Aksaray University, Aksaray, Turkey.

ORCID-Profile: Fazile Nur Ekinci Akdemir, Mustafa Can Güler, Ayhan Tanyeli, Fatih Mehmet Kandemir, Sefa Küçükler

Zitieren

APA

Ekinci Akdemir, F. N., Güler, M. C., Eraslan, E., Tanyeli, A., Yildirim, S., Kandemir, F. M., & Küçükler, S. (2026). The Effects of Galangin Mitigating Doxorubicin‐Induced Hepatorenal Injury. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70669

Vancouver

Ekinci Akdemir FN, Güler MC, Eraslan E, Tanyeli A, Yildirim S, Kandemir FM, et al. The Effects of Galangin Mitigating Doxorubicin‐Induced Hepatorenal Injury. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70669

BibTeX
@article{EkinciAkdemir2026,
  author = {Ekinci Akdemir, Fazile Nur and Güler, Mustafa Can and Eraslan, Ersen and Tanyeli, Ayhan and Yildirim, Serkan and Kandemir, Fatih Mehmet and Küçükler, Sefa},
  title = {The Effects of Galangin Mitigating Doxorubicin‐Induced Hepatorenal Injury},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.70669}
}
Kostenlos starten →